On CNBC’s “Halftime Report: Final Trades,” Shannon Saccocia of Boston Private said Quest Diagnostics Inc (NYSE:DGX) is expected to grow 4% to 5% on the top line during 2023.
Don’t forget to check out our premarket coverage here
Stephen Weiss of Short Hills Capital Partners recommended buying U.S. 6-Month Treasury Bill.
Read Next: Kellogg, United Natural Foods And 2 Other Stocks Insiders Are Selling
Photo: Shutterstock
